Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

NCT00005857 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: docetaxel

Sponsor

City of Hope Medical Center

Collaborators

[object Object]